Am J Physiol Cell Physiol AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 295: C514-C520, 2008. First published May 28, 2008; doi:10.1152/ajpcell.00032.2008
0363-6143/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/C514    most recent
00032.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Galloway, E.
Right arrow Articles by Lentsch, A. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galloway, E.
Right arrow Articles by Lentsch, A. B.

RECEPTORS AND SIGNAL TRANSDUCTION

Activation of hepatocytes by extracellular heat shock protein 72

Elizabeth Galloway,2 Thomas Shin,1 Nadine Huber,1 Thorsten Eismann,1 Satoshi Kuboki,1 Rebecca Schuster,1 John Blanchard,1 Hector R. Wong,2 and Alex B. Lentsch1

1The Laboratory of Trauma, Sepsis and Inflammation Research, Department of Surgery, University of Cincinnati, Cincinnati, Ohio; and 2Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio

Submitted 23 January 2008 ; accepted in final form 22 May 2008

Heat shock protein (HSP) 72 is released by cells during stress and injury. HSP-72 also stimulates the release of cytokines in macrophages by binding to Toll-like receptors (TLR) 2 and 4. Circulating levels of HSP-72 increase during hepatic ischemia-reperfusion injury. The role of extracellular HSP-72 (eHSP-72) in the injury response to ischemia-reperfusion is unknown. Therefore, the objective of the present study was to determine whether eHSP-72 has any direct effects on hepatocytes. Primary mouse hepatocytes were treated with purified human recombinant HSP-72. Conditioned media were evaluated by ELISA for the cytokines, TNF-{alpha}, IL-6, and macrophage inflammatory protein 2 (MIP-2). Stimulation of hepatocytes with eHSP-72 did not induce production of TNF{alpha} or IL-6 but resulted in dose-dependent increases in MIP-2 production. To evaluate the pathway responsible for this response, expression of TLR2 and TLR4 was confirmed on hepatocytes by immunohistochemistry. Hepatocyte production of MIP-2 was significantly decreased in hepatocytes obtained from TLR2 or TLR4 knockout mice. MIP-2 production was found to be partially dependent on NF-{kappa}B because inhibition of NF-{kappa}B with Bay 11-7085 significantly decreased eHSP-72-induced MIP-2 production. Inhibitors of p38 mitogen-activated protein kinase or c-Jun NH2-terminal kinase had no effect on production of MIP-2 induced by eHSP-72. The data suggest that eHSP-72 binds to TLR2 and TLR4 on hepatocytes and signals through NF-{kappa}B to increase MIP-2 production. The fact that eHSP-72 did not increase TNF-{alpha} or IL-6 production may be indicative of a highly regulated signaling pathway downstream from TLR.

liver; chemokines; Toll-like receptors; nuclear factor-{kappa}B; inflammation



Address for reprint requests and other correspondence: A. B. Lentsch, Dept. of Surgery, Univ. of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0558 (e-mail: alex.lentsch{at}uc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.